Fisetin
3 · 3′ · 4′ · 7-tetrahydroxyflavone · 7 · 3′ · 4′-trihydroxyflavonol · 5-deoxyquercetin
Last updated
At a glance
Overview
Why Fisetin Made It Into Longevity Stacks#
Fisetin is the flavonoid that actually earned its keep. When the Mayo Clinic screened ten natural compounds head-to-head for senolytic activity in 2018, fisetin came out on top — more potent at selectively killing senescent "zombie" cells than quercetin, luteolin, or any of the other usual suspects. That single paper kicked off a wave of human trials and turned a cheap strawberry-derived flavonol into the default entry-level senolytic for the longevity and looksmaxxing community.
The appeal for physique-focused users is straightforward: it's oral, it's OTC, it's cheap, it has no hormonal activity, and it slots into any protocol — blast, cruise, PCT, or natty — without interfering with anything. Most people run it as a monthly "hit-and-run" pulse (two consecutive days, then nothing for a month) to clear accumulated senescent cells and dampen the chronic low-grade inflammation they secrete. The practical payoffs users report over 6–12 months tend to show up as better recovery, less joint stiffness, clearer skin, and lower inflammatory markers — not dramatic, but consistent with what a real senolytic should do.
"We identified the natural product fisetin as one of the most potent senotherapeutic drugs, selectively inducing apoptosis in senescent cells." — Yousefzadeh et al., EBioMedicine (2018)
Below we'll break down the mechanism (SCAP inhibition, Bcl-2/Bcl-xL, PI3K/AKT), the clinical anchor dose (20 mg/kg × 2 days monthly, straight from the Mayo AFFIRM protocol), the crude-powder-vs-liposomal bioavailability question, the quercetin stack logic, realistic side effects, and the specific use-case protocols — post-cycle cleanup, looksmaxxing skin/inflammation stack, joint/tendon adjunct — worth actually running.
How Fisetin works
Fisetin is a naturally occurring flavonol — the same chemical family as quercetin and kaempferol — that the Mayo Clinic senolytic screen flagged as the most potent senotherapeutic of ten flavonoids tested. Its value to physique-focused and longevity-minded users comes from a single trick done well: it transiently disables the survival pathways that keep senescent cells alive, lets them die off by apoptosis, and then clears out of the system fast enough that you're not chronically inhibiting anything.
Selective Senolysis via Bcl-2 / Bcl-xL Inhibition#
Senescent cells — stressed, non-dividing, but metabolically active cells — accumulate with age, oxidative load, and (relevant for AAS users) prolonged harsh orals or chronic inflammation. They survive by upregulating anti-apoptotic proteins in the Bcl-2 family (Bcl-2, Bcl-xL, Bcl-w), collectively part of the Senescent Cell Anti-Apoptotic Pathways (SCAPs). Fisetin inhibits these proteins, tipping senescent cells into apoptosis while largely sparing healthy proliferating and quiescent cells.
"We identified the natural product fisetin as one of the most potent senotherapeutic drugs, selectively inducing apoptosis in senescent cells." — Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. EBioMedicine, 2018
This is the mechanism that makes the hit-and-run protocol (20 mg/kg × 2 days, monthly) coherent — you only need enough exposure to trigger apoptosis in the current senescent-cell pool. Practically, this is what underlies the slow improvements users report in joint stiffness, skin quality, and baseline inflammation.
PI3K/AKT Suppression and SASP Dampening#
Senescent cells don't just sit there — they secrete a cocktail of inflammatory cytokines (IL-6, IL-8, MCP-1, TNF-α) known as the Senescence-Associated Secretory Phenotype (SASP). That chronic, low-grade inflammatory drip is what drives age-related tendon dysfunction, slow recovery, skin laxity, and elevated hs-CRP on bloodwork.
"Fisetin, a flavone present in fruits and vegetables, is a naturally occurring senolytic that inhibits BCL-2/BCL-xL and PI3K/AKT pathways, producing apoptotic clearance of senescent cells." — Kirkland JL, Tchkonia T. Journal of Internal Medicine, 2020
By hitting PI3K/AKT — another SCAP node — fisetin both triggers senolysis and suppresses NF-κB-driven SASP output. For lifters running heavy blocks or for anyone on a long AAS run, that means less of the background inflammatory noise that blunts recovery between sessions.
Nrf2 Activation and Antioxidant Defense#
Beyond senolysis, fisetin activates the Nrf2/NQO1 axis, upregulating endogenous antioxidant enzymes (glutathione, superoxide dismutase, catalase, NAD(P)H quinone oxidoreductase). This is the same cytoprotective pathway sulforaphane and curcumin lean on.
"Liposomal and lipid-based formulations of fisetin enhanced oral bioavailability by several fold compared to free fisetin, underscoring the impact of formulation on systemic exposure." — Kumar H, Chand P, Pachal S, et al. Molecular Pharmaceutics, 2023
Translation for a lifter: the oxidative stress generated by heavy training, high-androgen states, and harsh 17α-alkylated orals gets partially buffered. This is a modest effect — don't expect it to replace TUDCA or a real liver-support protocol — but it's the reason fisetin pairs cleanly with a post-oral-blast cleanup window.
Bone and Tissue Remodeling Effects#
In a 2024 Mayo trial in postmenopausal women, monthly fisetin pulses shifted bone resorption markers, consistent with clearance of senescent osteocytes and osteoclast precursors.
"Participants received 20 mg/kg fisetin orally on 2 consecutive days per month, a regimen which was well tolerated for up to 9 months, with evidence of modulation of bone resorption markers." — Farr JN, Atkinson EJ, Achenbach SJ, et al. JCI Insight, 2024
That's the first solid human readout that the mouse-model senolysis story actually translates into a measurable tissue-level signal. Extrapolating cautiously: if senescent osteocytes respond, senescent chondrocytes and tendon fibroblasts plausibly respond too — which is the mechanistic basis for stacking fisetin alongside BPC-157 or TB-500 during a joint-healing block.
Neuroinflammation and BBB Penetration#
Fisetin is lipophilic and crosses the blood-brain barrier in animal models, where it reduces microglial activation, dampens neuroinflammatory cytokines, and modestly boosts glutathione in CNS tissue. Human cognition data is still thin — preclinical work in Alzheimer's and tauopathy models is the strongest signal, and human trials are in progress. The practical take: if you're already running a longevity stack (NMN, urolithin A, tadalafil for cerebral perfusion), the monthly fisetin pulse is a mechanistically reasonable add-on for the "cognition and inflammaging" angle rather than a standalone nootropic.
Putting It Together#
The clean way to think about fisetin: it's a monthly senescent-cell reset button layered on top of a daily longevity stack. The Bcl-2/PI3K mechanism is well-characterized, the Nrf2 and SASP-dampening effects are real but modest, and the bone-turnover data is the first human readout that gives the mouse story genuine translational weight. It's not a performance compound, it's not anabolic, and you won't feel it acutely — but the mechanism is sound, the dosing is cheap and low-burden, and the downside is negligible for anyone not in the contraindicated groups.
Protocol
| Level | Dose | Frequency | Notes |
|---|---|---|---|
| Low | 500–1000 mg/kg | Custom | Documented entry-level range |
| Mid | 1500–2000 mg/kg | Custom | Most commonly studied range |
| High | 2000–3000 mg/kg | Custom | Hit-and-run protocol: once daily for 2 consecutive days, repeated monthly. Clinical anchor is 20 mg/kg/day × 2 days (Mayo AFFIRM-LITE). Always take with a fatty meal — crude fisetin is nearly useless on an empty stomach. |
Cycle length & outcomes
Documented cycle
1–52 weeks
Plateau after
52 wks
Cycle Length & Cadence#
Fisetin doesn't cycle like an anabolic or a peptide — it pulses. The whole mechanistic premise is hit-and-run senolysis: flood the system for 2 consecutive days, clear a fraction of senescent cells, then let the body go weeks without the compound before the next pulse. Daily dosing is mechanistically pointless and wastes material.
The anchor protocol is 20 mg/kg/day × 2 consecutive days, repeated monthly, lifted directly from the Mayo Clinic trials.
"Participants received 20 mg/kg fisetin orally on 2 consecutive days per month, a regimen which was well tolerated for up to 9 months, with evidence of modulation of bone resorption markers." — Farr JN et al., JCI Insight (2024)
"This clinical trial uses oral fisetin at 20 mg/kg/day for 2 consecutive days monthly as the senolytic intervention in older adults, following the same dosing approach as prior Mayo Clinic protocols." — ClinicalTrials.gov NCT03675724
Dose Ladder by Goal#
| Goal | Cadence | Per-dose-day | Monthly total | Notes |
|---|---|---|---|---|
| First-time tolerance check | 2 days, once | 500–1000 mg | 1–2 g | Gauges GI tolerance before committing to the full dose |
| Standard longevity pulse | 2 days × monthly | 1500 mg | 3 g | Community default, ~20 mg/kg for an 75 kg user |
| Aggressive / heavier users | 2–3 days × monthly | 2000 mg | 4–6 g | Matches Mayo 20 mg/kg at 100 kg bodyweight; no evidence more is better |
| Post-blast AAS cleanup | 2 days, once mid-PCT | 1500–2000 mg | 3–4 g | Single pulse after oral-heavy finisher; pair with TUDCA/milk thistle |
| Liposomal / phytosome | 2 days × monthly | 500–1000 mg | 1–2 g | ~3–5× more bioavailable, dose down accordingly |
Crude fisetin must be taken with a high-fat meal — eggs, MCT/olive oil, peanut butter, full-fat yogurt. Dosed on an empty stomach it's nearly worthless due to poor solubility and aggressive phase-II conjugation.
"Liposomal and lipid-based formulations of fisetin enhanced oral bioavailability by several fold compared to free fisetin, underscoring the impact of formulation on systemic exposure." — Kumar H et al., Molecular Pharmaceutics (2023)
Loading, Tapering, Onset#
- No loading phase. The first pulse is the full pulse.
- No taper. Short half-life (~3 h parent compound) and intermittent dosing mean there's nothing to wean off.
- Onset is not subjective. Unlike a peptide or an oral, you generally don't "feel" fisetin on dose day beyond occasional mild GI effects or a transient headache. The biological work — SCAP disruption and apoptotic clearance — happens over the 24–72 h after the pulse.
- Perceivable effects (better skin tone, less morning joint stiffness, improved recovery) tend to emerge over 2–4 monthly pulses, not after a single dose. Many users feel nothing subjective and that's consistent with mechanism.
Bloodwork Cadence#
Fisetin is low-risk enough that most users don't run dedicated labs for it. If you're already pulling a standard AAS or longevity panel:
- hs-CRP — the one marker plausibly responsive to an effective senolytic pulse over months. Trend it quarterly.
- CBC + CMP — covers liver/kidney baseline; no expected fisetin-specific deviations.
- Lipids — unaffected by fisetin directly, but tracked anyway if you're on cycle.
- Coagulation (PT/INR) — only if you're on warfarin or high-dose antiplatelet therapy. If so, skip fisetin entirely rather than trying to monitor around it.
No need for hormonal panels — fisetin has zero HPTA, aromatase, or 5-AR activity. It runs cleanly through blast, cruise, and PCT.
Total Run Length#
There's no upper bound. The Mayo trials have run the monthly pulse for up to 9 months continuously without safety signals, and the community approach is to run it indefinitely — it's cheap, food-derived, and the pulsing cadence means cumulative exposure stays modest. Reasonable review points at 6 and 12 months to reassess hs-CRP and subjective markers (sleep, recovery, skin). If you see nothing after a year of consistent pulses, it's a signal to reallocate spend to other longevity inputs (NMN, urolithin A, rapamycin) rather than escalate dose.
Risks & mistakes
Common (most users)#
- Mild GI upset / loose stools on dose days at 1.5–2 g crude powder. Take with a fatty meal (eggs, avocado, peanut butter, olive oil), split AM/PM instead of a single bolus, or drop to liposomal at ~500 mg.
- Transient headache on dose day 1 or 2. Hydrate aggressively and ensure you're eating — fisetin's mild vasodilatory/antioxidant flush plus fasted dosing is usually the culprit.
- Yellow-green tint to urine or stool — purely cosmetic, the flavonoid pigment passing through. Not a warning sign.
- Mild fatigue or "off" feeling on dose days. Schedule the pulse over a weekend or light training days; by day 3–4 it's gone.
Uncommon (dose-dependent or individual)#
- Easier bruising / prolonged bleed time from minor cuts — fisetin has mild antiplatelet activity like quercetin. If you're already running high-dose fish oil, nattokinase, or daily aspirin, run the pulse in isolation or stagger by several days.
- Drug-interaction risk via CYP3A4 / CYP2C9 inhibition at gram-level doses. Users taking a narrow-therapeutic-index drug (tacrolimus, certain anti-epileptics, some statins), space fisetin ≥12 h away or skip it. Check a CMP if you're stacking with anything hepatically cleared.
- Reduced non-heme iron absorption with frequent high-dose flavonoid intake. Not an issue on a monthly pulse; becomes one if you're dosing daily. Check ferritin if you're a menstruating woman or endurance athlete running fisetin more often than once per month.
- GI intolerance at 2–3 g single doses — back off to 1–1.5 g with food, or switch to a liposomal at 500 mg.
Rare but serious#
- Bleeding episodes (unusual epistaxis, extended bleeding from cuts, GI bleeding) in users combining fisetin with therapeutic-dose anticoagulants or antiplatelets. Stop immediately and get a coag panel.
- Allergic reaction — rare, but flavonoid hypersensitivity exists. Rash, angioedema, wheeze → stop and treat as any food-allergic reaction.
- Unexpected hypoglycemia in users on insulin or sulfonylureas (fisetin has mild glucose-lowering activity in animal models). Monitor glucose on dose days if this applies.
Hard contraindications#
- Pregnancy or active attempts to conceive — no safety data at supra-dietary doses. Skip it.
- Active chemotherapy — CYP interactions and antioxidant activity may blunt certain oxidative-mechanism agents. Your oncology team decides, not a forum.
- Scheduled surgery within 1–2 weeks — antiplatelet effect. Move the pulse or skip that month.
- Warfarin or high-dose antiplatelet therapy — additive bleeding risk is not worth it for a monthly flavonoid. Don't run the two together.
Gender considerations and PCT#
Fisetin has no hormonal activity — no aromatase effect, no androgen-receptor binding, no HPTA suppression, no impact on prolactin or SHBG. Same dose applies to men and women. It's one of the few longevity compounds you can run straight through a blast, cruise, or PCT without worrying about interference, and it pairs cleanly with the usual post-cycle support (TUDCA, milk thistle, low-dose tadalafil, aromatase control). No PCT is required and none is needed after stopping. The only window to pause is pregnancy or attempted conception — otherwise it's compatible with effectively every AAS, SARM, peptide, and looksmaxxing stack people run.
"Participants received 20 mg/kg fisetin orally on 2 consecutive days per month, a regimen which was well tolerated for up to 9 months, with evidence of modulation of bone resorption markers." — Farr et al., JCI Insight (2024)
Stack & combine
Multipliers applied when these compounds run together. Values > 1 indicate a bonus on that axis. Tap a partner to expand the mechanism.
| Partner | Type | Lean | Fat loss | Recovery |
|---|---|---|---|---|
| additive | ×1.00 | ×1.00 | ×1.05 |
FAQ — Fisetin
Research & citations
5 studies cited on this page.
Conclusion
Fisetin earns its place in the longevity stack as a clinically-backed senolytic — simple to run, cheap, and safe for most. It won't turn back the clock overnight, but it's one of the few OTC compounds with actual human data matching the mouse hype.
Key takeaways:
- Standard protocol: 1500–2000 mg crude fisetin (or 500–1000 mg liposomal) with a high-fat meal, once daily for 2 days, repeated monthly
- Based on Mayo Clinic's 20 mg/kg × 2 day pulsed senolytic regimen, now replicated in ongoing human trials
- Always dose with fat to avoid wasting material (bioavailability is the main bottleneck)
- Often stacked with quercetin (500–1000 mg on dose days), NMN/NR, and urolithin A for a comprehensive longevity stack
- Side effects are mild and rare — some GI upset or transient yellow urine; avoid during pregnancy, active chemo, or just before surgery
- You likely won't "feel" anything acute, but fisetin is a sensible and low-risk play for systemic inflammation, healthy aging, and skin recovery
For anyone serious about longevity or looksmaxxing, monthly fisetin pulses are an accessible, evidence-aligned anchor for a modern senolytic protocol.